After problems with earlier samples, a fuller picture of the outbreak is emerging following another round of testing.
Differences were driven by improved response rates for patients with pneumonia who were treated with ceftolozane–tazobactam.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果